| Imaging β-amyloid burden in aging and dementia CC Rowe, S Ng, U Ackermann, SJ Gong, K Pike, G Savage, TF Cowie, ... Neurology 68 (20), 1718-1725, 2007 | 1276 | 2007 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1129 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 1019 | 2011 |
| β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease KE Pike, G Savage, VL Villemagne, S Ng, SA Moss, P Maruff, CA Mathis, ... Brain 130 (11), 2837-2844, 2007 | 968 | 2007 |
| The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of … KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ... International psychogeriatrics 21 (4), 672-687, 2009 | 908 | 2009 |
| Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ... The Lancet Neurology 7 (2), 129-135, 2008 | 786 | 2008 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 453 | 2010 |
| Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imaging CE Leyton, VL Villemagne, S Savage, KE Pike, KJ Ballard, O Piguet, ... Brain 134 (10), 3030-3043, 2011 | 398 | 2011 |
| Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease VL Villemagne, KE Pike, D Darby, P Maruff, G Savage, S Ng, ... Neuropsychologia 46 (6), 1688-1697, 2008 | 310 | 2008 |
| β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ... Neurology 74 (2), 121-127, 2010 | 257 | 2010 |
| Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ... Annals of neurology 74 (6), 905-913, 2013 | 251 | 2013 |
| Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study KE Pike, KA Ellis, VL Villemagne, N Good, G Chételat, D Ames, C Szoeke, ... Neuropsychologia 49 (9), 2384-2390, 2011 | 169 | 2011 |
| Larger temporal volume in elderly with high versus low beta-amyloid deposition G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ... Brain 133 (11), 3349-3358, 2010 | 169 | 2010 |
| Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease G Verdile, SM Laws, D Henley, D Ames, AI Bush, KA Ellis, NG Faux, ... Molecular psychiatry 19 (1), 69-75, 2014 | 134 | 2014 |
| The ART of loss: Aβ imaging in the evaluation of Alzheimer’s disease and other dementias VL Villemagne, MT Fodero-Tavoletti, KE Pike, R Cappai, CL Masters, ... Molecular neurobiology 38, 1-15, 2008 | 132 | 2008 |
| Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease G Chetelat, VL Villemagne, KE Pike, KA Ellis, P Bourgeat, G Jones, ... Brain 134 (3), 798-807, 2011 | 122 | 2011 |
| Subjective cognitive decline: level of risk for future dementia and mild cognitive impairment, a meta-analysis of longitudinal studies KE Pike, MG Cavuoto, L Li, BJ Wright, GJ Kinsella Neuropsychology review 32 (4), 703-735, 2022 | 106 | 2022 |
| Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging J Fripp, P Bourgeat, O Acosta, P Raniga, M Modat, KE Pike, G Jones, ... Neuroimage 43 (3), 430-439, 2008 | 102 | 2008 |
| Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study A Bahar-Fuchs, G Chételat, VL Villemagne, S Moss, K Pike, CL Masters, ... Journal of Alzheimer's Disease 22 (4), 1081-1087, 2010 | 94 | 2010 |
| Blood-borne amyloid-β dimer correlates with clinical markers of Alzheimer's disease VL Villemagne, KA Perez, KE Pike, WM Kok, CC Rowe, AR White, ... Journal of Neuroscience 30 (18), 6315-6322, 2010 | 87 | 2010 |
Christopher Cleon RoweUniversity of Melbourne在 austin.org.au 的电子邮件经过验证
